X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (17) 17
animals (9) 9
cell line, tumor (9) 9
apoptosis (8) 8
cancer (8) 8
mice (8) 8
differentiation (7) 7
inhibition (7) 7
biochemistry & molecular biology (6) 6
female (6) 6
gene expression (6) 6
4-hydroxynonenal (5) 5
article (5) 5
biology (5) 5
expression (5) 5
growth (5) 5
male (5) 5
oncology (5) 5
proliferation (5) 5
proteins (5) 5
signal transduction (5) 5
analysis (4) 4
cancer cells (4) 4
carcinoma, pancreatic ductal - metabolism (4) 4
carcinoma, pancreatic ductal - pathology (4) 4
cell biology (4) 4
cell growth (4) 4
cell proliferation - drug effects (4) 4
dna damage (4) 4
gene-expression (4) 4
ligands (4) 4
medicine, research & experimental (4) 4
multidisciplinary sciences (4) 4
pancreatic cancer (4) 4
pancreatic neoplasms - metabolism (4) 4
pancreatic neoplasms - pathology (4) 4
stem cells (4) 4
tumors (4) 4
xenograft model antitumor assays (4) 4
adenocarcinoma (3) 3
aldehydes - pharmacology (3) 3
article subject (3) 3
cancer therapies (3) 3
cell culture (3) 3
cell cycle (3) 3
cell proliferation (3) 3
cells (3) 3
colon cancer (3) 3
cyclodextrins (3) 3
disease models, animal (3) 3
dna damage - drug effects (3) 3
endocrinology & metabolism (3) 3
genes (3) 3
genetic aspects (3) 3
kinases (3) 3
lipid peroxidation (3) 3
lipid-peroxidation (3) 3
mechanisms (3) 3
melanoma (3) 3
nanoparticles (3) 3
oxidative stress (3) 3
pancreatic neoplasms - drug therapy (3) 3
pancreatic neoplasms - genetics (3) 3
product (3) 3
prostate cancer (3) 3
proto-oncogene proteins p21 - genetics (3) 3
proto-oncogene proteins p21 - metabolism (3) 3
review (3) 3
review article (3) 3
activated-receptor-gamma (2) 2
adenocarcinoma - metabolism (2) 2
adenocarcinoma - pathology (2) 2
adult (2) 2
aged (2) 2
alpha-enolase (2) 2
antineoplastic agents - pharmacology (2) 2
antioxidants - metabolism (2) 2
antitumor-activity (2) 2
binding (2) 2
breast cancer (2) 2
c-myc (2) 2
carcinoma, pancreatic ductal - drug therapy (2) 2
carcinoma, pancreatic ductal - genetics (2) 2
care and treatment (2) 2
cell adhesion (2) 2
cell differentiation - drug effects (2) 2
cell survival - drug effects (2) 2
colon (2) 2
colonic neoplasms - pathology (2) 2
colorectal cancer (2) 2
digestive system diseases (2) 2
dna (2) 2
drug carriers - chemistry (2) 2
drug delivery systems (2) 2
drug dosages (2) 2
drug stability (2) 2
drug-resistance (2) 2
drugs (2) 2
emt (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature, ISSN 0028-0836, 4/2019, Volume 568, Issue 7752, pp. 410 - 414
Pancreatic ductal adenocarcinoma (PDAC) remains recalcitrant to all forms of cancer treatment and carries a dismal 5-year survival rate of 8% 1 . Inhibition of... 
Journal Article
NATURE, ISSN 0028-0836, 10/2014, Volume 514, Issue 7524, pp. 628 - 628
Journal Article
Nature, ISSN 0028-0836, 02/2017, Volume 542, Issue 7641, pp. 362 - 366
Journal Article
Cell Reports, ISSN 2211-1247, 06/2016, Volume 16, Issue 1, pp. 133 - 147
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 12/2017, Volume 77, Issue 23, pp. 6651 - 6666
Acquired and intrinsic resistance to receptor tyrosine kinase inhibitors (RTKi) represents a major hurdle in improving the management of clear cell renal cell... 
MEK INHIBITION | MODELS | ONCOLOGY | EPIGENETIC MODIFICATIONS | KINASE INHIBITORS | MECHANISMS | PROLIFERATION | DRUG-RESISTANCE | CANCER | EXPRESSION | EMT | Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors | Lung Neoplasms - drug therapy | Bevacizumab - pharmacology | Phosphorylation | Humans | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Sunitinib | Lung Neoplasms - secondary | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Carcinoma, Renal Cell - pathology | Mice, SCID | Receptor Protein-Tyrosine Kinases - metabolism | Mice, Inbred ICR | Xenograft Model Antitumor Assays | Pyrroles - pharmacology | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Kidney Neoplasms - pathology | Mice | Kidney Neoplasms - drug therapy | Drug Resistance, Neoplasm - physiology | Tyrosine | Syngeneic grafts | Gene expression | Drug resistance | Anticancer properties | Bevacizumab | Metastases | Allografts | Antiangiogenics | Xenografts | Impact resistance | Histone methyltransferase | Protein-tyrosine kinase receptors | Antitumor activity | Vascular endothelial growth factor | Protein-tyrosine kinase | Clear cell-type renal cell carcinoma | Apoptosis | sunitinib | renal cell carcinoma | kinome reprogramming | patient-derived xenograft | resistance | EZH2
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 08/2016, Volume 97, pp. 24 - 37
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2126 - 2126
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 11/2012, Volume 47, Issue 4, pp. 686 - 694
Journal Article
Cancer Research, ISSN 0008-5472, 03/2015, Volume 75, Issue 6, pp. 1091 - 1101
Journal Article
ACS CHEMICAL BIOLOGY, ISSN 1554-8929, 10/2019, Volume 14, Issue 10, pp. 2215 - 2223
Proteolysis targeting chimeras are bifunctional small molecules capable of recruiting a target protein of interest to an E3 ubiquitin ligase that facilitates... 
INHIBITION | THERAPY | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | DRUG-RESISTANCE | KNOCKDOWN | EXPRESSION
Journal Article